Journal of Addiction and Clinical Research

Sign up for email alert when new content gets added: Sign up

Use of implantable buprenorphine beyond FDA limit: A case report

Author(s): Michael C Campbell*

Buprenorphine is used to treat opioid use disorders. Compliance can often be a clinical challenge. There are many patient factors involved in making oral buprenorphine a successful treatment. Implantable buprenorphine improves the chances of compliance and successful treatment. Currently, the FDA only approves implantable buprenorphine for one year of use. Presented is a case of implantable buprenorphine beyond the FDA limit.

Full-Text | PDF